Chatham Capital Group Inc. Trims Stake in Addus HomeCare Co. (NASDAQ:ADUS)

Chatham Capital Group Inc. lowered its stake in Addus HomeCare Co. (NASDAQ:ADUS) by 3.5% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 20,882 shares of the company’s stock after selling 765 shares during the period. Chatham Capital Group Inc.’s holdings in Addus HomeCare were worth $2,618,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Quarry LP purchased a new stake in Addus HomeCare in the 3rd quarter valued at approximately $28,000. Smartleaf Asset Management LLC lifted its stake in Addus HomeCare by 324.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock valued at $35,000 after buying an additional 214 shares in the last quarter. Farther Finance Advisors LLC lifted its stake in Addus HomeCare by 9,150.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after buying an additional 366 shares in the last quarter. Parkside Financial Bank & Trust lifted its stake in Addus HomeCare by 38.6% in the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock valued at $67,000 after buying an additional 148 shares in the last quarter. Finally, KBC Group NV lifted its stake in Addus HomeCare by 49.1% in the 4th quarter. KBC Group NV now owns 814 shares of the company’s stock valued at $102,000 after buying an additional 268 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the transaction, the chief executive officer now directly owns 79,397 shares of the company’s stock, valued at $9,905,569.72. This trade represents a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Roberton James Stevenson sold 2,250 shares of the firm’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the transaction, the executive vice president now directly owns 10,217 shares in the company, valued at $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.60% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the company. StockNews.com lowered Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th. Macquarie reissued an “outperform” rating and set a $129.00 price target on shares of Addus HomeCare in a research note on Thursday, February 27th. JMP Securities assumed coverage on Addus HomeCare in a research note on Monday, December 16th. They set an “outperform” rating and a $150.00 price target on the stock. Citizens Jmp raised Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. Finally, Stephens reduced their price target on Addus HomeCare from $153.00 to $142.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 26th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $132.78.

Addus HomeCare Trading Down 0.9 %

Shares of ADUS opened at $95.29 on Friday. The firm has a market capitalization of $1.73 billion, a P/E ratio of 21.81, a price-to-earnings-growth ratio of 1.41 and a beta of 0.97. The stock’s fifty day simple moving average is $119.86 and its 200 day simple moving average is $125.12. Addus HomeCare Co. has a twelve month low of $87.88 and a twelve month high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing the consensus estimate of $1.35 by ($0.09). The firm had revenue of $297.14 million during the quarter, compared to analysts’ expectations of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Sell-side analysts predict that Addus HomeCare Co. will post 4.59 earnings per share for the current year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.